Remove Animal Testing Remove Immune Response Remove RNA
article thumbnail

A therapy candidate for fatal prion diseases turns off disease-causing gene

Broad Institute

CRISPRoff silences the targeted gene by adding methyl groups, chemical tags that prevent the gene from being transcribed or read into RNA and so from being expressed as protein. When the researchers tested CRISPRoff’s ability to silence the prion protein gene, they found that it was effective and stable.

Disease 142